Acknowledgement
This work was financially supported by the National Natural Science Foundation of China (81970237).
References
- Abonnenc, M., Nabeebaccus, A.A., Mayr, U., Barallobre-Barreiro, J., Dong, X., Cuello, F., Sur, S., Drozdov, I., Langley, S.R., Lu, R., et al. (2013). Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ. Res. 113, 1138-1147. https://doi.org/10.1161/CIRCRESAHA.113.302400
- Bauersachs, J. (2010). Regulation of myocardial fibrosis by MicroRNAs. J. Cardiovasc. Pharmacol. 56, 454-459. https://doi.org/10.1097/FJC.0b013e3181ee81df
- Bhatt, H.V. and Fischer, G.W. (2015). Atrial fibrillation: pathophysiology and therapeutic options. J. Cardiothorac. Vasc. Anesth. 29, 1333-1340. https://doi.org/10.1053/j.jvca.2015.05.058
- Brundel, B.J., Van Gelder, I.C., Henning, R.H., Tieleman, R.G., Tuinenburg, A.E., Wietses, M., Grandjean, J.G., Van Gilst, W.H., and Crijns, H.J. (2001). Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103, 684-690. https://doi.org/10.1161/01.CIR.103.5.684
- Dawson, K., Wakili, R., Ordog, B., Clauss, S., Chen, Y., Iwasaki, Y., Voigt, N., Qi, X.Y., Sinner, M.F., Dobrev, D., et al. (2013). MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 127, 1466-1475, 1475e1461-1428.
- Dobrev, D. and Nattel, S. (2008). Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J. Cardiovasc. Pharmacol. 52, 293-299. https://doi.org/10.1097/FJC.0b013e318171924d
- Edgley, A.J., Krum, H., and Kelly, D.J. (2012). Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-beta. Cardiovasc. Ther. 30, e30-e40. https://doi.org/10.1111/j.1755-5922.2010.00228.x
- Fuster, V., Ryden, L.E., Asinger, R.W., Cannom, D.S., Crijns, H.J., Frye, R.L., Halperin, J.L., Kay, G.N., Klein, W.W., Levy, S., et al. (2001). ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur. Heart J. 22, 1852-1923. https://doi.org/10.1053/euhj.2001.2983
- Guo, S., Meng, X.W., Yang, X.S., Liu, X.F., Ou-Yang, C.H., and Liu, C. (2018). Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes. Acta Pharmacol. Sin. 39, 195-204. https://doi.org/10.1038/aps.2017.92
- Han, P., Li, W., Lin, C.H., Yang, J., Shang, C., Nuernberg, S.T., Jin, K.K., Xu, W., Lin, C.Y., Lin, C.J., et al. (2014). A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514, 102-106. https://doi.org/10.1038/nature13596
- Hennemeier, I., Humpf, H.U., Gekle, M., and Schwerdt, G. (2014). Role of microRNA-29b in the ochratoxin A-induced enhanced collagen formation in human kidney cells. Toxicology 324, 116-122. https://doi.org/10.1016/j.tox.2014.07.012
- January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland, J.C., Jr., Conti, J.B., Ellinor, P.T., Ezekowitz, M.D., Field, M.E., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 64, e1-e76. https://doi.org/10.1016/j.jacc.2014.04.029
- Karreth, F.A., Tay, Y., Perna, D., Ala, U., Tan, S.M., Rust, A.G., DeNicola, G., Webster, K.A., Weiss, D., Perez-Mancera, P.A., et al. (2011). In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147, 382-395. https://doi.org/10.1016/j.cell.2011.09.032
- Koch, S., Tugues, S., Li, X., Gualandi, L., and Claesson-Welsh, L. (2011). Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183. https://doi.org/10.1042/BJ20110301
- Lee, K.W., Everett, T.H., 4th, Rahmutula, D., Guerra, J.M., Wilson, E., Ding, C., and Olgin, J.E. (2006). Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 114, 1703-1712. https://doi.org/10.1161/CIRCULATIONAHA.106.624320
- Li, J., Guo, Z.Y., Gao, X.H., Bian, Q., Jia, M., Lai, X.L., Wang, T.Y., Bian, X.L., and Wang, H.Y. (2015). Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1alpha, VEGF and TGF-beta1. PLoS One 10, e0118481. https://doi.org/10.1371/journal.pone.0118481
- Maurer, B., Stanczyk, J., Jungel, A., Akhmetshina, A., Trenkmann, M., Brock, M., Kowal-Bielecka, O., Gay, R.E., Michel, B.A., Distler, J.H., et al. (2010). MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 62, 1733-1743.
- Mir, S.A., Chatterjee, A., Mitra, A., Pathak, K., Mahata, S.K., and Sarkar, S. (2012). Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J. Biol. Chem. 287, 2666-2677. https://doi.org/10.1074/jbc.M111.246173
- Nattel, S., Burstein, B., and Dobrev, D. (2008). Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 1, 62-73. https://doi.org/10.1161/CIRCEP.107.754564
- Neef, S., Dybkova, N., Sossalla, S., Ort, K.R., Fluschnik, N., Neumann, K., Seipelt, R., Schondube, F.A., Hasenfuss, G., and Maier, L.S. (2010). CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ. Res. 106, 1134-1144. https://doi.org/10.1161/CIRCRESAHA.109.203836
- Rahman, F., Kwan, G.F., and Benjamin, E.J. (2014). Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. 11, 639-654. https://doi.org/10.1038/nrcardio.2014.118
- Ramdas, V., McBride, M., Denby, L., and Baker, A.H. (2013). Canonical transforming growth factor-beta signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29. Am. J. Pathol. 183, 1885-1896. https://doi.org/10.1016/j.ajpath.2013.08.027
- Ren, X.P., Wu, J., Wang, X., Sartor, M.A., Jones, K., Qian, J., Nicolaou, P., Pritchard, T.J., and Fan, G.C. (2009). MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119, 2357-2366. https://doi.org/10.1161/CIRCULATIONAHA.108.814145
- Salmena, L., Poliseno, L., Tay, Y., Kats, L., and Pandolfi, P.P. (2011). A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358. https://doi.org/10.1016/j.cell.2011.07.014
- Shan, H., Zhang, Y., Lu, Y., Zhang, Y., Pan, Z., Cai, B., Wang, N., Li, X., Feng, T., Hong, Y., et al. (2009). Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc. Res. 83, 465-472. https://doi.org/10.1093/cvr/cvp130
- Sheng, J., Shim, W., Wei, H., Lim, S.Y., Liew, R., Lim, T.S., Ong, B.H., Chua, Y.L., and Wong, P. (2013). Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts. J. Cell. Mol. Med. 17, 1345-1354. https://doi.org/10.1111/jcmm.12114
- Smadja, D.M., Nunes, H., Juvin, K., Bertil, S., Valeyre, D., Gaussem, P., and Israel-Biet, D. (2014). Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis. Pathol. Biol. (Paris) 62, 391-394. https://doi.org/10.1016/j.patbio.2014.07.006
- Tao, H., Cao, W., Yang, J.J., Shi, K.H., Zhou, X., Liu, L.P., and Li, J. (2016). Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis. Cardiovasc. Pathol. 25, 381-389. https://doi.org/10.1016/j.carpath.2016.05.005
- Tao, H., Shi, K.H., Yang, J.J., Huang, C., Zhan, H.Y., and Li, J. (2014a). Histone deacetylases in cardiac fibrosis: current perspectives for therapy. Cell. Signal. 26, 521-527. https://doi.org/10.1016/j.cellsig.2013.11.037
- Tao, H., Yang, J.J., Chen, Z.W., Xu, S.S., Zhou, X., Zhan, H.Y., and Shi, K.H. (2014b). DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology 323, 42-50. https://doi.org/10.1016/j.tox.2014.06.006
- Tao, H., Yang, J.J., Shi, K.H., Deng, Z.Y., and Li, J. (2014c). DNA methylation in cardiac fibrosis: new advances and perspectives. Toxicology 323, 125-129. https://doi.org/10.1016/j.tox.2014.07.002
- Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S.M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011). Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357. https://doi.org/10.1016/j.cell.2011.09.029
- Uchida, S. and Dimmeler, S. (2015). Long noncoding RNAs in cardiovascular diseases. Circ. Res. 116, 737-750. https://doi.org/10.1161/CIRCRESAHA.116.302521
- van Rooij, E., Sutherland, L.B., Liu, N., Williams, A.H., McAnally, J., Gerard, R.D., Richardson, J.A., and Olson, E.N. (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 103, 18255-18260. https://doi.org/10.1073/pnas.0608791103
- van Rooij, E., Sutherland, L.B., Thatcher, J.E., DiMaio, J.M., Naseem, R.H., Marshall, W.S., Hill, J.A., and Olson, E.N. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U. S. A. 105, 13027-13032. https://doi.org/10.1073/pnas.0805038105
- Wang, K., Liu, F., Zhou, L.Y., Long, B., Yuan, S.M., Wang, Y., Liu, C.Y., Sun, T., Zhang, X.J., and Li, P.F. (2014). The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ. Res. 114, 1377-1388. https://doi.org/10.1161/CIRCRESAHA.114.302476
- Wang, K., Long, B., Zhou, J., and Li, P.F. (2010). miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J. Biol. Chem. 285, 11903-11912. https://doi.org/10.1074/jbc.M109.098004
- Wang, X., Liu, T., Zhao, Z., and Li, G. (2015). Noncoding RNA in cardiac fibrosis. Int. J. Cardiol. 187, 365-368. https://doi.org/10.1016/j.ijcard.2015.03.195
- Yan, Z., Qu, K., Zhang, J., Huang, Q., Qu, P., Xu, X., Yuan, P., Huang, X., Shao, Y., Liu, C., et al. (2015). CD147 promotes liver fibrosis progression via VEGF-A/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells. Clin. Sci. (Lond.) 129, 699-710. https://doi.org/10.1042/CS20140823
- Yang, L., Engeland, C.G., and Cheng, B. (2013). Social isolation impairs oral palatal wound healing in sprague-dawley rats: a role for miR-29 and mR-203 via VEGF suppression. PLoS One 8, e72359. https://doi.org/10.1371/journal.pone.0072359
- Zhang, Y., Huang, X.R., Wei, L.H., Chung, A.C., Yu, C.M., and Lan, H.Y. (2014). miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling. Mol. Ther. 22, 974-985. https://doi.org/10.1038/mt.2014.25